Dr Amanda Saracino
Scleroderma Skin Research Postdoctoral Fellowship
Department of Medicine
27 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Refractory IgG4−related skin disease successfully treated with intravenous methylprednisolone and baricitinib
DOI: 10.1016/j.jdcr.2026.07.0492026
Journal article
Facial Cosmetic Therapy Use Among Patients With Systemic Sclerosis: An Australian Cohort Study
DOI: 10.1002/acr.801432026
Journal article
Towards effective targeted therapies in morphea
DOI: 10.23736/S2784-8671.25.08413-02026
Journal article
Mucocutaneous Disease Activity and Damage Accrual in Systemic Lupus Erythematosus: Analyses From the Asia-Pacific Lupus Collaboration Longitudinal Cohort Study
DOI: 10.1002/acr.800502026
Journal article
Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort Study
DOI: 10.1111/ajd.701792025
Journal article
Predicting trajectories of lung function decline in systemic sclerosis-related interstitial lung disease
DOI: 10.1093/rheumatology/keaf2702024
Journal article
Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index
DOI: 10.1002/art.42939
RECENT SCHOLARLY WORKS
2024
Journal article
Atypical morphoea, a herald of two malignancies: Lung adenocarcinoma and a neuroendocrine tumour
DOI: 10.1177/239719832412544422023
Journal article
Reply to Letter to the Editor: Sclerosis terminology in the spotlight
DOI: 10.1016/j.jaad.2023.06.0092023
Journal article
Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsies
DOI: 10.1007/s00403-023-02541-5